May 07, 2021
Here’s a roundup of the latest coronavirus-related news.
Pfizer and BioNTech have initiated rolling submission of their Biologics License Application for full approval of BNT162b2.
May 06, 2021
Flip the Pharmacy announced that Parata Systems is now a national program sponsor.
May 05, 2021
Technology and mobile health apps can be valuable tools in diabetes management.
May 04, 2021
Bill S.1388 would require the FTC to examine recent merger activity of PBMs and how it may be affecting patients and independent community pharmacies.
More opportunities are emerging for pharmacists to fine-tune their patients’ regimens and serve as important access points for individuals experiencing mental health crises.
In the final episode of the series, Dr. Lee highlights what's next in enhancing patient care for those with limited English proficiency.
May 03, 2021
Here’s a preview of the featured content to watch for this week on Drug Topics®.
Dapagliflozin (Farxiga; AstraZeneca) is the first SGLT2 inhibitor approved for the treatment of chronic kidney disease regardless of diabetes status.
April 30, 2021
